The further study of CTGF is important for the pathogenesis, therapeutic mechanism and the clinical treatment of hepatic fibrosis and cirrhosis.
有关CTGF的进一步研究将对于揭示肝纤维化及肝硬化发病和治疗机理以及临床诊治等具有重要的意义。
Conclusion liver mass in patients with liver cirrhosis is related to hepatic hemodynamics, indices for liver fibrosis and liver pathology.
结论肝硬化患者肝组织质量与肝血流动力学、肝纤维化指标及病理分期有关。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
The liver injury being caused by various harmful factors were manifested as hepatic necrosis, fatty liver, cholestasis, liver fibrosis, liver cirrhosis and liver cancer and so on.
各种有害因素所致的肝损伤可表现为肝坏死、脂肪肝、胆汁郁积、肝纤维化、肝硬化及肝癌等。
And there was no relationship in patients with liver cirrhosis. IGF-1 might be related with liver damage and hepatic fibrosis in patients with CHB.
CHB患者血清igf - 1水平异常与肝脏的损害相关，而且可能与CHB患者肝脏纤维组织增生相关联。
And there was no relationship in patients with liver cirrhosis. IGF-1 might be related with liver damage and hepatic fibrosis in patients with CHB.
CHB患者血清igf - 1水平异常与肝脏的损害相关，而且可能与CHB患者肝脏纤维组织增生相关联。
应用推荐